pl
en
Country
pl
Language
en
Janssen.tv Janssen.tv MENU

ADHD and Behavioral Disorders – Case Study

Speciality: Psychiatry
Language : Polski
Duration : 00:51:40
Date: November 8, 2012

ADHD and Behavioral Disorders – Case Study

Lecturers

Prof. Tomasz Wolańczyk
Prof. Tomasz Wolańczyk Poland

Other in: Psychiatry

How to optimize outcomes in schizophrenia? - Prof. Tényi, Prof. Janka
Psychiatry Live conference How to optimize outcomes in schizophrenia? - Prof. Tényi, Prof. Janka Prof. Tamás Tényi, Ph.D, DSc
Prof. Zoltán Janka, MD, Ph.D
EN
How to optimize outcomes in schizophrenia? - Prof. Correll, Prof. Janka
Psychiatry Live conference How to optimize outcomes in schizophrenia? - Prof. Correll, Prof. Janka Prof Christoph Correll
Prof. Zoltán Janka, MD, Ph.D
EN
How to optimize outcomes in schizophrenia? - Q&A
Psychiatry Live conference How to optimize outcomes in schizophrenia? - Q&A Prof Christoph Correll
Prof. Tamás Tényi, Ph.D, DSc
Prof. Zoltán Janka, MD, Ph.D
EN
Prof. Stephen Stahl Psychopharmacology Workshop - PART 2
Psychiatry Live conference Prof. Stephen Stahl Psychopharmacology Workshop - PART 2 Prof Stephen M. Stahl
EN
2
PL
RO
Prof. Stephen Stahl Psychopharmacology Workshop - PART 1
Psychiatry Live conference Prof. Stephen Stahl Psychopharmacology Workshop - PART 1 Prof Stephen M. Stahl
EN
2
PL
RO
How to change the course of schizophrenia?
Psychiatry Live conference How to change the course of schizophrenia? Several lecturers
EN
2
PL
RO
How to change the course of schizophrenia
Psychiatry Live conference How to change the course of schizophrenia Prof Robin Emsley
EN
1
PL
Central European Schizophrenia Meeting in Warsaw Recommended
Psychiatry Live conference Central European Schizophrenia Meeting in Warsaw Prof. Istvan Bitter, Ph.D, DSc
Prof. Agata Szulc, MD, Ph.D
Prof Robin Emsley
EN
2
PL
RO
Is Schizophrenia a disease of recurrent nature?
Psychiatry Live conference Is Schizophrenia a disease of recurrent nature? Prof. Tomasz Sobów, MD, Ph.D
Prof. Przemysław Bieńkowski, MD, Ph.D
Prof. Agata Szulc, MD, Ph.D
PL
Jak poprawić skuteczność leczenia schizofrenii - najnowsze standardy 2015
Psychiatry, Neurology Jak poprawić skuteczność leczenia schizofrenii - najnowsze standardy 2015 Prof. Jerzy Samochowiec, MD, Ph.D
PL
Long-term treatment of schizophrenia with antipsychotic medications
Psychiatry Live conference Long-term treatment of schizophrenia with antipsychotic medications Prof. Istvan Bitter, Ph.D, DSc
Prof. Marek Jarema, MD, Ph.D
PL
Debate: The time between visit and initiation of therapy – the role of cognitive functions in the therapeutic process.
Psychiatry Open broadcast Debate: The time between visit and initiation of therapy – the role of cognitive functions in the therapeutic process. Several lecturers
PL
Long-term outlook for the treatment of schizophrenia — the practical aspects of long-acting antipsychotic medications
Psychiatry Live conference Long-term outlook for the treatment of schizophrenia — the practical aspects of long-acting antipsychotic medications Several lecturers
PL
Our achievements in the therapy of schizophrenia: aspirations and reality
Psychiatry Open broadcast Our achievements in the therapy of schizophrenia: aspirations and reality Prof. Tomasz Sobów, MD, Ph.D
PL
Comprehensive therapy and rehabilitation in schizophrenia
Psychiatry Live conference Comprehensive therapy and rehabilitation in schizophrenia Prof. Jolanta Rabe - Jabłońska, MD, Ph.D
PL
New options for more effective treatment of schizophrenia: the future or the present? Long-acting antipsychotic medications: from theory to practice
Psychiatry Live conference New options for more effective treatment of schizophrenia: the future or the present? Long-acting antipsychotic medications: from theory to practice Prof. Przemysław Bieńkowski, MD, Ph.D
PL
Non-adherence with antipsychotic medications in schizophrenia: a rule or an exception?
Psychiatry Live conference Non-adherence with antipsychotic medications in schizophrenia: a rule or an exception? Prof. Marek Jarema, MD, Ph.D
PL
Cognitive disorders and neurodegeneration in schizophrenia: — Can the disease progression be stopped?
Psychiatry Open broadcast Cognitive disorders and neurodegeneration in schizophrenia: — Can the disease progression be stopped? Prof. Agata Szulc, MD, Ph.D
PL
Biological and mental causes of non-compliance in chronic disease treatment
Psychiatry Open broadcast Biological and mental causes of non-compliance in chronic disease treatment Tomasz Tafliński, MD, Ph.D
PL
Isolated weight disorders
Psychiatry Isolated weight disorders Artur Kołakowski, MD, Ph.D
PL
Title: Access to reimbursable medicines — legal and medical aspects, part 2
Psychiatry Open broadcast Title: Access to reimbursable medicines — legal and medical aspects, part 2 attorney Andrzej Kurianowicz
Anna Mosiołek, MD, Ph.D
PL
SM Dźwirzyno – Heritage of innovation
Psychiatry SM Dźwirzyno – Heritage of innovation Prof. Bartosz Łoza, MD, Ph.D
PL
Title: Access to reimbursable medications — legal and medical aspects, part 1
Psychiatry Open broadcast Title: Access to reimbursable medications — legal and medical aspects, part 1 Anna Mosiołek, MD, Ph.D
attorney Wojciech Wojtal
PL
Optimum treatment timing in the first episode of schizophrenia
Psychiatry Open broadcast Optimum treatment timing in the first episode of schizophrenia Prof. Bartosz Łoza, MD, Ph.D
PL
How to diagnose ADHD in children and how to help them, Vol. 1
Psychiatry How to diagnose ADHD in children and how to help them, Vol. 1 Artur Kołakowski, MD, Ph.D
PL
How to diagnose ADHD in children and how to help them, Vol. 2
Psychiatry How to diagnose ADHD in children and how to help them, Vol. 2 Artur Kołakowski, MD, Ph.D
PL